Newborn screening is a vital public health program that involves the testing of newborns for certain genetic, metabolic, hormonal, and functional disorders that may not be apparent at birth. This early detection allows for timely intervention and treatment to prevent or minimize the long-term effects of these conditions. Several companies are known for their involvement in providing products and services for newborn screening.
Latest Newborn screening Companies Update
Sep 2023 Waters Corporation, a US-based analytical laboratory equipment and software manufacturer, is spending $16 million (Rs 133 crore) to establish a global capability center (GCC) in Bengaluru's RMZ Ecoworld. Patil led the trip, which met with Waters to discuss potential ways to increase their presence in Karnataka. Waters Corporation has also asked for assistance in forming alliances with regional pharmaceutical behemoths that produce biosimilars to work to export medications to other markets.
April 2022 Natus Medical Inc. has agreed to be acquired by healthcare-focused investment company ArchiMed for $1.2 billion and taken private, according to the medical equipment manufacturer. Shareholders of Natus will receive $33.50 in cash, a premium of 28.6% over the stock's most recent closing price. The business produces medical tools and supplies for identifying and tracking conditions that impact the brain, muscles, nerves, and neonates. Over the past year, shares of Natus have decreased by 9%. Sales of several medical gadgets have suffered because of the COVID-19 pandemic's impact on the market for elective surgeries.List of Newborn screening Key companies in the market
Waters (US)
SCIEX (US)
Natus Medical Incorporated (US)
PerkinElmer Inc. (US)
Masimo Corporation (US)
Bio-Rad Laboratories Inc. (US)
Agilent Technologies Inc. (US)
GENERAL ELECTRIC (Boston)
Medtronic PLC (Ireland)
Trivitron Healthcare (India)
New-Born Screening Market Highlights:
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)